Press Announcement

New Patented Alzheimer’s Disease Treatment — Based on “Rocket Science” — Available at No Cost for Medical R&D

(Hartford, Connecticut, U.S.A.)   Remarkable Technologies, Inc. (www.RemarkableTechnologies.com), a 21-year-old technology-development firm, unveiled today what it believes is a promising new treatment approach for Alzheimer’s Disease, an incurable disease that affects 5.3 million people in the U.S. and nearly 44 million worldwide.

Eric Knight, Founder and President of Remarkable Technologies, Inc., said, “We are certainly excited about the technology and its potential. Given the magnitude of the medical problem, we want to help get the technology into the research pipeline as quickly as possible. Hence the no-fee license.”

Knight continued, “As a company, we have made the unusual decision to forgo patent licensing fees for R&D. This is too important of an innovation to keep it bottled up or to inhibit the early stages of medical research.  Too many people are suffering. Too many people are dying.”

Remarkable Technologies, Inc. is providing a no-fee, non-exclusive patent license for R&D to bona fide medical researchers, scientists, and organizations. Information is available on the special Web site the company has created: www.AlzheimersTreatmentInvention.com.

Radio waves are the key to the technology

The company’s patented technology (U.S. Patent 9,037,268) is based on years of research by scientists regarding the effects of radio waves on the human brain. With the widespread and growing use of cell phones, research has intensified to see if these types of radio frequency (RF) devices cause cancer or have other negative consequences. Surprisingly, not only has no harm been noted in the research, but some studies have showed a positive effect on brain function.

Recent studies exposed RF energy to mice that have been genetically modified to exhibit Alzheimer’s disease. Mice and humans share 95% of their genes, providing an appropriate reference for comparative studies. The results of the RF studies with mice were surprising and unexpected. One study in particular was the research conducted by the University of South Florida. (Research study, as published in the Journal of Alzheimer’s Disease, is available at www.AlzheimersTreatmentInvention.com.) The following is from the Abstract of the published study: “Although caution should be taken in extrapolating these mouse studies to humans, we conclude that EMF [electromagnetic field / radio frequency energy] exposure may represent a non-invasive, non-pharmacologic therapeutic against Alzheimer’s disease….” The study concludes “… we believe that the current lack of an effective therapeutic against [Alzheimer’s Disease], in concert with this study’s surprising findings, justifies EMF exposure as a non-invasive, non-pharmacologic approach worthy of vigorous investigation.”

Eric Knight, with expertise in the fields of RF antenna design and RF propagation, analyzed the mice-based research dating back over five years. Inspired by the magnitude of the Alzheimer’s disease problem and the hint of a potential solution, Knight set off to invent, design, and develop an RF-delivery system for treating humans. After years of research, development, and testing, Knight was successful. On May 19, 2015, the U.S. Patent and Trademark Office granted a patent — U.S. Patent 9,037,268 — on his technology innovation. (Knight has assigned the patent rights to his company, Remarkable Technologies, Inc.)

Alzheimer’s disease treatment invention has aerospace roots

Knight said that the “ah-ha” moment was the inspiration to apply an antenna technology that is used on the exterior surfaces of rockets: “15 years ago, I was working on an aerospace project that required a thin, flat, and flexible antenna system that could wrap around the cylinder of a rocket airframe. A few years ago, while brainstorming on the Alzheimer’s challenge, a light bulb went on: The antennas used on the rocket airframe could be flipped around so that the RF energy that would normally transmit outwards from the rocket could transmit inwards to provide therapy to a patient’s brain. That’s the moment the invention was born.”

Goal: Turn Alzheimer’s disease into a very manageable affliction

Once brain cells are destroyed they cannot be repaired. Thus, the goal of Knight’s invention is to provide maintenance therapy to those in the earliest stages of the disease, and sustain the brain’s normal health for the lifetime of the patients. According to Knight, “In much the same way as HIV/AIDS has become a manageable disease for many, the hope is that our treatment technology can contribute — perhaps in combination with other therapies that will emerge — to patients living otherwise normal lives.”

Patent provides nearly unbounded research opportunities

Knight continued, “The scientific studies to date have primarily focused on the particular RF frequencies emitted from cell phones — around 900 MHz. But the chance that this frequency is somehow also magically the optimum for the treatment of Alzheimer’s disease is extremely unlikely. So that’s why our patent encompasses a much broader spectrum of RF and a wide variety of signal types and intensities.”

Knight went on to say, “Our patent covers a huge swath of frequencies; a wide range of signal intensities; various signal-modulation modes; fixed, selective, and spiral RF-treatment patterns; treatment times and regimens that are essentially unbounded; manual and computer-controlled systems; and much more. In short: Our patent spans an enormous range of RF-applied options so that researchers may have the broadest possible brush to discover optimum treatment protocols.” The company’s tested technology implementations are compliant with pertinent FCC regulations.

Versatile configurations and deployments

According to Knight, “The versatile nature of our patented technology allows for a wide range of technology deployments. For instance, our technology can be deployed as a simple, wearable device — such as a hat or cap. Or embedded in a pillow or mattress, for treatment while sleeping. Or as part of a sophisticated, computer-controlled RF-delivery system — akin to CAT or MRI technology systems.”

Knight concluded, “A lot of work still needs to be done; we just scratched the surface with this new technology. And the need is urgent: By 2025, the number of people in the U.S. with Alzheimer’s is expected to increase 40% to 7.1 million, and nearly triple by 2050 to 13.8 million. By allowing scientists and researchers to experiment with our patented technology — at no cost — we hope to unleash the power of many brilliant minds in parallel. We need to put a halt to this terrible disease, right now.”

About Remarkable Technologies, Inc.

Remarkable Technologies, Inc. was founded in 1994 by inventor and entrepreneur, Eric Knight. His vision was to create a company that provides innovative products and services that enhance business and empower people — and those remain the company’s guiding principles today.

The company is actively involved in a diverse array of projects and programs that include novel computer technologies, athletic training systems, aerospace initiatives, advanced RF-based systems, environmental “green” innovations, Internet-based business services, educational outreach programs, inventor-assistance programs, consumer-product innovations, and public service initiatives.

Since its inception, the company has made conscious efforts to be a good corporate citizen in its local and regional communities. This community-support philosophy is an important cornerstone of the company.

Remarkable Technologies, Inc. is a privately held corporation headquartered in Farmington, Connecticut, U.S.A.